0
0
0
International Pharmaceutical Transparency Act of 2019
10/28/2022, 1:46 AM
Congressional Summary of HR 5381
International Pharmaceutical Transparency Act of 2019
This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
Read the Full Bill
Current Status of Bill HR 5381
Bill HR 5381 is currently in the status of Bill Introduced since December 10, 2019. Bill HR 5381 was introduced during Congress 116 and was introduced to the House on December 10, 2019. Bill HR 5381's most recent activity was Referred to the Subcommittee on Health. as of December 11, 2019
Bipartisan Support of Bill HR 5381
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 5381
Primary Policy Focus
HealthPotential Impact Areas
- Consumer affairs
- Drug safety, medical device, and laboratory regulation
- Prescription drugs
Alternate Title(s) of Bill HR 5381
International Pharmaceutical Transparency Act of 2019
To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug to list the country of origin of each of the drug's active ingredients.
International Pharmaceutical Transparency Act of 2019
Comments
Sponsors and Cosponsors of HR 5381
Latest Bills
Strengthening America’s Turning Point Act
Bill S 1518July 26, 2026
Unlocking Native Lands and Opportunities for Commerce and Key Economic Developments Act of 2025
Bill S 3383July 25, 2026
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Bill HR 3029July 25, 2026
Transparency in Billing Act of 2026
Bill HR 8684July 25, 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Bill S 4472July 25, 2026
Connected Vehicle Security Act of 2026
Bill S 4429July 25, 2026
Protecting American Taxpayers Act
Bill S 4952July 25, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill S 4784July 25, 2026
Renewing the African American Civil Rights Network Act
Bill S 4767July 25, 2026
National Plan for Epilepsy Act
Bill S 494July 25, 2026
